Novavax Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Novavax

Access the complete profile.

Novavax Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	621511 Medical Laboratories
Additional NAICS Codes	5417 Scientific Research & Development Services 541711 Research & Development in Biotechnology
Address	21 Firstfield Rd Gaithersburg, MD 20878

Novavax's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Novavax's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Novavax is classified as operating in the Medical Laboratories industry, NAICS Code 621511.

Novavax is a publicly traded company on using the ticker symbol NVAX. Detailed information on company financials and operating reports can be found here: : NVAX

Novavax Annual Revenue and Growth Rate

Novavax	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Novavax's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that Novavax is developing and marketing. Novavax doesn't have any recent trademark applications, indicating Novavax is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
RESVAX Vaccines for human use only; vaccine adjuvants for human use only	01/18/2022
WE FOCUS ON THIS SO THEY CAN FOCUS ON THAT Pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, vaccines, and clinical trials and post-market trials related to pharmaceuticals, biologics, and vaccines	12/20/2021
CREATING TOMORROW'S VACCINES TODAY Pharmaceutical preparations for the treatment of infectious diseases; vaccines; adjuvants for medical purposes	12/13/2021

See all trademarks and details in the Full Report.

Market Share of Novavax's Largest Competitors

A competitive analysis shows these companies are in the same general field as Novavax, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PHYSICIANS IMMUNODIAGNOSTIC LABORATORY	Burbank, CA	100
ACCU REFERENCE MEDICAL LAB LIMITED LIABILITY	Linden, NJ	100
CENTOGENE US	Cambridge, MA	88
LATARA ENTERPRISE	Pomona, CA	61
TELIGENT PHARMA	Vineland, NJ	46
COVID CLINIC	Huntington Beach, CA	37
VIKOR SCIENTIFIC	Charleston, SC	33
BIOTHERANOSTICS	San Diego, CA	31
SHERMAN-ABRAMS LABORATORY	Brooklyn, NY	31

Nearby Competitors

These companies are similar in business line and location to Novavax. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
GENEDX	Gaithersburg, MD	100
NOVAVAX	Gaithersburg, MD	93
MENON MEDICAL CENTER	Kensington, MD	4
IMAGIMED	Germantown, MD	4
NEURODIAGNOSTICS	Rockville, MD	3
C MANAGEMENT	Rockville, MD	3

Future Competition: Novavax's Fastest Growing Competitors

These companies are in the same general field as Novavax and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)